CBLL logo

CERIBELL INC

CBLLNASDAQ
🏆 #2522 by market capUS Equity
$24.84▲ $0.38 (+1.51%)
After hours · at close
🔔
Track CBLL
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 1.5%
7d▲ 2.5%
14d▼ 0.7%
30d▲ 4.7%
ytd▲ 13.4%
1y▲ 116.4%
🏦Market Cap
$942M
Small Cap
📈Revenue Growth (YoY)
+31.7%
High Growth
📊Gross Margin
88.9%
High
💵FCF Margin
—
⚖️P/S Ratio
8.9x
Elevated
Otter Score
76
Good

Trading Snapshot

Day Range
$24.57 – $25.19
52-Week Range
$10.85 – $25.63
Volume
$2.90B
Avg Volume
$2.86B
Shares Outstanding
37.9M
Next Earnings
Dec 13, 2026

Fundamentals Snapshot

Annual Revenue
$89M
Last Q Revenue
$28M
P/E Ratio
—
P/S Ratio
8.9x
EPS (TTM)
$-1.76
Dividend Yield
—
Dilution (1yr)
+19.3%

Why Investors Own CBLL

  • ✓High-growth profile — revenue up +54.7% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 60% gross margin and 12% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CBLL logo

CERIBELL INC

CBLL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$89M▲ +36.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
87.9%▲ +1.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$58M▲ +47.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$42M▲ +14.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
37.2M▲ +19.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$18M▼ −$154M YoY
StockOtter · stockotter.space

About CERIBELL INC

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
76/100

Analyst Price Target

ⓘ
Average Target
$32.08
▲ +29.2% Upside
High Target$37.78
Low Target$29.50
Based on 11 analysts

Latest News & Updates

🚀
Barron’s·2h ago

CERIBELL INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Bloomberg·5h ago

Analysts lift CBLL price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Barron’s·1d ago

CERIBELL INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.